Interestingly enough, the same study identified two novel germline mutations in the NPM1 gene in patients suffering from dyskeratosis congenita, and thus linked impaired 2′-O-Me at multiple levels to this ribosomopathy, characterized by bone marrow failure and associated symptoms. This evidence concerns the gene NPM1 and dyskeratosis congenita.